Skip to main content
Equibles

BARCLAYS PLC

Position in OCGN — Ocugen, Inc.

CIK 312069 LONDON, X0
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$560,865
+$143,448 QoQ
Shares Held
366,579
+59.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 147 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Derivatives in OCGN

reported options exposure · as of Mar 31, 2022
CallValue
$0
CallShares
0
PutValue
$22,440
PutShares
6,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. OCGN ranks #151 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in OCGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $560,865 366,579
2026-03-31 $417,417 230,618
2025-12-31 $212,625 157,500
2025-06-30 $58,588 60,400
2025-03-31 $221,887 314,288
2024-12-31 $364,999 453,415
2024-09-30 $576,438 581,087
2024-06-30 $440,871 284,433
2023-03-31 $93,661 109,802
2022-12-31 $1,672,954 1,286,888
2022-09-30 $2,139,990 1,202,242
2022-06-30 $30,830 13,582
2022-03-31 $22,440 6,800